Dear Editor,

A 59-year-old man presented with a 9-month history of transfusion-dependent anaemia, hepatomegaly (2 cm) and splenomegaly (6 cm). F-18 fluorodeoxyglucose (FDG) positron emission tomography computed tomography (PET/CT) showed gross hepatosplenomegaly (Fig. [1a](#Fig1){ref-type="fig"}) that was eumetabolic (Fig. [1b](#Fig1){ref-type="fig"}), raising the possibility that the cause might be non-neoplastic. However, bone marrow examination showed a small population of suspicious T cells with no clear histopathological patterns. The T cell receptor (TCR) gamma gene was clonally rearranged on polymerase chain reaction, suggesting that the hepatosplenomegaly might be related to a clonal T cell neoplasm. Fig. 1A case of hepatosplenic T cell lymphoma with negative positron emission tomography. **a** Computed tomography of the abdomen, showing gross hepatosplenomegaly. **b** Positron emission tomography showing that the hepatosplenomegaly was eumetabolic. **c** The spleen showed red pulp infiltration by atypical lymphoid cells. **d** The liver showed infiltration of sinusoids (*arrows*) by atypical lymphoid cells. **e**--**h** Immunoperoxidase staining, showing that the lymphoma cells were positive for CD3 (**e**), negative for CD4 and CD8 (**f**, **g**), and positive for TCRγ (**h**)

Splenectomy and liver biopsy were performed. Histologically, there was cord expansion and sinusoidal infiltration in the splenic red pulp by small atypical lymphoid cells (Fig. [1c](#Fig1){ref-type="fig"}). These neoplastic lymphoid cells were also found as small aggregates in the hepatic sinusoids (Fig. [1d](#Fig1){ref-type="fig"}). On immunophenotyping, the lymphoid cells were CD3+, CD4−, CD8−, TIA-1+, TCRβ− and TCRγ+ (Fig. [1e--h](#Fig1){ref-type="fig"}). The overall features were consistent with hepatosplenic T cell lymphoma (HSTCL) of the γδ subtype.

PET/CT is used extensively in the staging and post-treatment follow-up of Hodgkin\'s lymphoma, where it is considered a standard of care \[[@CR1]\]. It is also regarded as highly sensitive in most aggressive and indolent B cell lymphomas \[[@CR2]\]. FDG uptake is usually proportional to histopathological grading, being very avid in high-grade lymphomas that are metabolically active. Although this pattern is generally observed in B cell lymphomas, it is undefined if FDG uptake also parallels the clinical behaviour in T cell lymphomas. In fact, PET/CT has been reported to be negative in some T cell malignancies, notably T-large granular lymphocyte leukaemia and T-prolymphocytic leukaemia \[[@CR3]\]. HSTCL is an aggressive lymphoma with a poor survival. It accounts for less than 1% of all lymphomas. Because HSTCL is rare, the application of PET/CT in its diagnosis and management has not been evaluated. FDG avidity had only been previously reported in a single case of HSTCL occurring after liver transplantation \[[@CR4]\]. Our case apparently had arisen de novo. The lymphoma was entirely FDG non-avid, constituting a diagnostic pitfall. Therefore, the role of PET/CT in the diagnosis and follow-up of T cell lymphomas may have to be carefully defined for each histopathological type \[[@CR5]\].
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